BR112022001056A2 - Métodos de tratamento de distúrbios do sono associados a dor - Google Patents

Métodos de tratamento de distúrbios do sono associados a dor

Info

Publication number
BR112022001056A2
BR112022001056A2 BR112022001056A BR112022001056A BR112022001056A2 BR 112022001056 A2 BR112022001056 A2 BR 112022001056A2 BR 112022001056 A BR112022001056 A BR 112022001056A BR 112022001056 A BR112022001056 A BR 112022001056A BR 112022001056 A2 BR112022001056 A2 BR 112022001056A2
Authority
BR
Brazil
Prior art keywords
pain
patient
sleep
methods
treating
Prior art date
Application number
BR112022001056A
Other languages
English (en)
Portuguese (pt)
Inventor
Gerard Marek
Katherine Tracy
Marci English
Mark Walzer
Beth Blauwet Mary
Michael Smith
Paul Blahunka
Original Assignee
Astellas Pharma Global Dev Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astellas Pharma Global Dev Inc filed Critical Astellas Pharma Global Dev Inc
Publication of BR112022001056A2 publication Critical patent/BR112022001056A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BR112022001056A 2019-07-23 2020-07-22 Métodos de tratamento de distúrbios do sono associados a dor BR112022001056A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201962877573P 2019-07-23 2019-07-23
PCT/US2020/043047 WO2021016338A1 (en) 2019-07-23 2020-07-22 Methods of treating sleep disorders associated with pain

Publications (1)

Publication Number Publication Date
BR112022001056A2 true BR112022001056A2 (pt) 2022-05-24

Family

ID=72047043

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112022001056A BR112022001056A2 (pt) 2019-07-23 2020-07-22 Métodos de tratamento de distúrbios do sono associados a dor

Country Status (10)

Country Link
US (1) US20220370468A1 (https=)
EP (1) EP4003357A1 (https=)
JP (1) JP2022541634A (https=)
KR (1) KR20220038344A (https=)
CN (1) CN114144183A (https=)
AU (1) AU2020318996A1 (https=)
BR (1) BR112022001056A2 (https=)
CA (1) CA3147752A1 (https=)
MX (1) MX2022000892A (https=)
WO (1) WO2021016338A1 (https=)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0320637D0 (en) * 2003-09-03 2003-10-01 Novartis Ag Organic compounds
MX350745B (es) * 2009-11-06 2017-09-14 Sk Biopharmaceuticals Co Ltd * El uso de un compuesto de carbamoilo para el tratamiento del sindrome de fibromialgia.
SG11201509989VA (en) * 2013-06-06 2016-01-28 Astellas Pharma Inc Benzothiophene compound

Also Published As

Publication number Publication date
KR20220038344A (ko) 2022-03-28
JP2022541634A (ja) 2022-09-26
MX2022000892A (es) 2022-03-11
AU2020318996A1 (en) 2022-02-03
CA3147752A1 (en) 2021-01-28
CN114144183A (zh) 2022-03-04
EP4003357A1 (en) 2022-06-01
WO2021016338A1 (en) 2021-01-28
US20220370468A1 (en) 2022-11-24

Similar Documents

Publication Publication Date Title
Shneerson Sleep medicine: a guide to sleep and its disorders
Neubauer Sleep problems in the elderly
Schulz et al. The development of sleep medicine: a historical sketch
Shapiro et al. ABC of sleep disorders. Sleep problems in patients with medical illness
Orlosky The Kleine-Levin syndrome: a review
Ting et al. Disorders of sleep: an overview
PT1261333E (pt) Utilizacao de topiramato para o tratamento e diagnostico de transtorno do sono relacionado com a respiracao e meios para realizar o metodo e o diagnostico
Mondardini et al. Update of recommendations for analgosedation in pediatric intensive care unit
Nicholson et al. Insomnia: A guide for medical practitioners
BR112022001056A2 (pt) Métodos de tratamento de distúrbios do sono associados a dor
Kamal et al. The effect of sleep hygiene and relaxation Benson on improving the quality of sleep among health failure patients: A literature review
Manber et al. Sleep disorders.
West Lectures on the Diseases of Infancy and Childhood
Scharf et al. Sleep disorders
Kotecha Surgical approaches to the management of sleep-disordered breathing
Mittal et al. Armodafanil for the treatment of Kleine-Levin syndrome
Adesina et al. 1222 These Boots Were Made for Walking, but Not Sleeping
Rouf et al. Use of Potassium Citrate in Restless Leg Syndrome (RLS)
Maloney The protective action of picrotoxin in prolonged surgical anesthesia with evipal
Redeker Sleep-disordered breathing in patients with heart failure: an update
Norfleet AN EXTREME CASE OF BRADYCARDIA
American Academy of Family Physicians Information from Your Family Doctor: Sleep Changes in Older Adults
Abraham et al. Case Study: Post-traumatic Stress Disorder “I Am Having Nightmares on My Back”
Smith et al. Discussion On The Psychoses Of The Climacteric
Cushny Discussion on Insomnia

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 5A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2841 DE 17-06-2025 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.